Similar articles

• Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.

  Zervos M, Martinez FJ, Amsden GW, Rothermel CD, Treadway G. Zervos M, et al. Int J Antimicrob Agents. 2007 Jan;29(1):56-61. doi: 10.1016/j.ijantimicag.2006.08.043. Int J Antimicrob Agents. 2007. PMID: 17189096 Clinical Trial.
• Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.

  Hillis GS, Pearson CV, Harding SA, Sutherland S, Ludlam CA, Marioni JC, Prescott RJ, Fox KA, Flapan AD. Hillis GS, et al. Am Heart J. 2004 Jul;148(1):72-9. doi: 10.1016/j.ahj.2004.01.016. Am Heart J. 2004. PMID: 15215794 Clinical Trial.
• Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone.

  Ericsson CD, DuPont HL, Okhuysen PC, Jiang ZD, DuPont MW. Ericsson CD, et al. J Travel Med. 2007 Sep-Oct;14(5):312-9. doi: 10.1111/j.1708-8305.2007.00144.x. J Travel Med. 2007. PMID: 17883462 Clinical Trial.
• Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.

  Milstone A, Patsimas J, Farzan D, Castaldo R, Singh H, Feurer I, Harnett J, Luke DR; PROPeR Use Study Group. Milstone A, et al. Clin Ther. 2005 Jun;27(6):926-39. doi: 10.1016/j.clinthera.2005.06.001. Clin Ther. 2005. PMID: 16117993 Clinical Trial.
• Single dose azithromycin for the treatment of uncomplicated otitis media.

  Arguedas A, Loaiza C, Soley C. Arguedas A, et al. Pediatr Infect Dis J. 2004 Feb;23(2 Suppl):S108-14. doi: 10.1097/01.inf.0000112524.71839.c6. Pediatr Infect Dis J. 2004. PMID: 14770073 Review.